methane has been researched along with sorafenib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dehneshin, N; Farzad, F; Hasanzade, Z; Raissi, H | 1 |
| Ahmed, AR; Alaaeldin, E; Allam, S; Elsadek, BE; Elsayed, MM; Mostafa, ME; Sarhan, HA; Shaykoon, MS | 1 |
| Chen, S; Feng, Y; Guo, L; Hu, Y; Huang, H; Lian, L; Wan, L; Wen, Z; Xu, K; Yan, X; Yang, Q; Zhang, M | 1 |
3 other study(ies) available for methane and sorafenib
| Article | Year |
|---|---|
Using molecular dynamics simulation to explore the binding of the three potent anticancer drugs sorafenib, streptozotocin, and sunitinib to functionalized carbon nanotubes.
Topics: Antineoplastic Agents; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Molecular Conformation; Molecular Dynamics Simulation; Nanotubes, Carbon; Sorafenib; Spectrum Analysis; Streptozocin; Sunitinib; Water | 2019 |
Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Body Weight; Carcinoma, Hepatocellular; Cell Proliferation; Drug Compounding; Drug Design; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver; Liver Neoplasms; Male; Nanotubes, Carbon; Niacinamide; Rats, Wistar; Sorafenib; Spectroscopy, Fourier Transform Infrared; Static Electricity | 2019 |
Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Delivery Systems; ErbB Receptors; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Mice; Mice, Nude; Nanotubes, Carbon; Neoplasm Transplantation; RNA, Small Interfering; Sorafenib | 2021 |